? The overall objective of this project is to develop a cancer biomarker discovery and validation platform for analyses e.g. of human blood plasma and other clinically relevant samples that will provide measurements that are: much more robust, of higher sensitivity, provide more than order of magnitude throughput, and have improved quantitative utility compared to existing platforms. The new platform will provide increased dynamic range, and thus proteome coverage, and allow quantitative measurements of candidate cancer biomarker proteins at concentrations that are presently problematic for broad proteome measurements (e.g. plasma protein concentrations similar to PSA and lower). The enhanced throughput of the platform will be realized in conjunction with improved quality of quantitative data (derived from increased robustness, higher run-to-run reproducibility, and increased sensitivity), providing greater confidence in proteomic data. Thus, the new platform will be a powerful tool for both candidate biomarker discovery and pre-clinical candidate validation, and with further refinement provide the basis for broad clinical application. The instrumental platform will be an integration of fast liquid chromatography (LC) based separations, a novel microfabricated array nanoelectrospray ionization (nanoESI) interface, and high resolution gas phase ion mobility separations coupled with accurate mass time-of-flight mass spectrometry. In the initial R21 phase, we will focus primarily on: (1) the development of a prototype instrument platform and the key nanoESI interface component; and (2) an initial evaluation of the platform's throughput, sensitivity, and robustness. The R33 Phase will focus on: (1) the further refinement of the platform, (2) the development of the informatics tools needed to support the platform's massive data production rates, and (3) the platform's evaluation in the context of high throughput quantitative proteomics measurements involving clinically relevant oncology-based human blood plasma samples and the comparison with existing assays for a number of low level protein biomarkers (e.g. PSA). The anticipated result of this project will be a robust high throughput platform with the potential for revolutionizing cancer biomarker discovery and validation, and its initial dissemination for clinical applications. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21CA126191-01
Application #
7224731
Study Section
Special Emphasis Panel (ZCA1-SRRB-9 (O1))
Program Officer
Rodriguez, Henry
Project Start
2006-09-28
Project End
2008-01-31
Budget Start
2006-09-28
Budget End
2008-01-31
Support Year
1
Fiscal Year
2006
Total Cost
$266,018
Indirect Cost
Name
Battelle Pacific Northwest Laboratories
Department
Type
DUNS #
032987476
City
Richland
State
WA
Country
United States
Zip Code
99352
Ibrahim, Yehia M; Baker, Erin S; Danielson 3rd, William F et al. (2015) Development of a New Ion Mobility (Quadrupole) Time-of-Flight Mass Spectrometer. Int J Mass Spectrom 377:655-662
Prost, Spencer A; Crowell, Kevin L; Baker, Erin S et al. (2014) Detecting and removing data artifacts in Hadamard transform ion mobility-mass spectrometry measurements. J Am Soc Mass Spectrom 25:2020-2027
Baker, Erin Shammel; Burnum-Johnson, Kristin E; Jacobs, Jon M et al. (2014) Advancing the high throughput identification of liver fibrosis protein signatures using multiplexed ion mobility spectrometry. Mol Cell Proteomics 13:1119-27
Crowell, Kevin L; Baker, Erin S; Payne, Samuel H et al. (2013) Increasing Confidence of LC-MS Identifications by Utilizing Ion Mobility Spectrometry. Int J Mass Spectrom 354-355:312-317
Xie, Fang; Smith, Richard D; Shen, Yufeng (2012) Advanced proteomic liquid chromatography. J Chromatogr A 1261:78-90
Tang, Keqi; Page, Jason S; Marginean, Ioan et al. (2011) Improving liquid chromatography-mass spectrometry sensitivity using a subambient pressure ionization with nanoelectrospray (SPIN) interface. J Am Soc Mass Spectrom 22:1318-25
Baker, Erin Shammel; Livesay, Eric A; Orton, Daniel J et al. (2010) An LC-IMS-MS platform providing increased dynamic range for high-throughput proteomic studies. J Proteome Res 9:997-1006
Ibrahim, Yehia M; Prior, David C; Baker, Erin S et al. (2010) Characterization of an Ion Mobility-Multiplexed Collision Induced Dissociation-Tandem Time-of-Flight Mass Spectrometry Approach. Int J Mass Spectrom 293:34-44
Shvartsburg, Alexandre A; Tang, Keqi; Smith, Richard D (2009) Two-dimensional ion mobility analyses of proteins and peptides. Methods Mol Biol 492:417-45
López-Ferrer, Daniel; Hixson, Kim K; Smallwood, Heather et al. (2009) Evaluation of a high-intensity focused ultrasound-immobilized trypsin digestion and 18O-labeling method for quantitative proteomics. Anal Chem 81:6272-7

Showing the most recent 10 out of 22 publications